NCT04447755 2025-10-03
E7080-G000-231
Merck Sharp & Dohme LLC
Phase 2 Completed
Clinical Trials
4 trialsNCT04154189 2024-07-22
A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma
Eisai Inc.
Phase 2 Completed
NCT06253364 2024-03-13
VETC is an Effective Marker for Postoperative Adjuvant Immunotherapy
Tongji Hospital
Completed
NCT03245151 2023-08-30
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
Eisai Inc.
Phase 1/2 Completed